The company inspects raw materials and components from suppliers upon arrival and conducts in-process and finished product testing according to established criteria. Manufacturing operations comply with current Good Manufacturing Practice (cGMP) requirements and undergo regular audits. Production, assembly, and packaging of DURAVYU occur in Watertown, Massachusetts. The active pharmaceutical ingredient (API) vorolanib is sourced from a single supplier, with other materials obtained from third-party vendors. Injector and packaging components, including needles, are purchased from multiple vendors, though historically each component has been sole-sourced. In October 2024, the company opened a new commercial manufacturing facility in Northbridge, Massachusetts, to support global manufacturing activities, including those for DURAVYU. YUTIQ® production also takes place in Watertown, Massachusetts, with the API sourced from Farmabios, needles from a third-party supplier, and other materials from additional third-party vendors. The company no longer produces YUTIQ® for sale in the United States but supplies it for sale by its partner in China.
Eyepoint Inc's Comment on Supply Chain
The company inspects raw materials and components from suppliers upon arrival and conducts in-process and finished product testing according to established criteria. Manufacturing operations comply with current Good Manufacturing Practice (cGMP) requirements and undergo regular audits. Production, assembly, and packaging of DURAVYU occur in Watertown, Massachusetts. The active pharmaceutical ingredient (API) vorolanib is sourced from a single supplier, with other materials obtained from third-party vendors. Injector and packaging components, including needles, are purchased from multiple vendors, though historically each component has been sole-sourced. In October 2024, the company opened a new commercial manufacturing facility in Northbridge, Massachusetts, to support global manufacturing activities, including those for DURAVYU. YUTIQ® production also takes place in Watertown, Massachusetts, with the API sourced from Farmabios, needles from a third-party supplier, and other materials from additional third-party vendors. The company no longer produces YUTIQ® for sale in the United States but supplies it for sale by its partner in China.
Sources:
Eyepoint Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Eyepoint Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
